Skip to content
  • Start
  • News
  • VIDEO
  • Podcast
  • Event
  • Premium
    • Premium Content
    • VC Database
    • Company Database
    • Soft Funding & Grants
    • Job Database
  • About BioStock
Log in Subscribe
Home / #BioStockSwe

#BioStockSwe

Cereno Scientific

Cereno Scientific comments on the Phase IIa study results

The study was conducted on the company's top candidate CS1 in the rare cardiovascular disease pulmonary arterial hypertension.

Intervju
Video
Elicera Therapeutics

Elicera's targeted virus against cancer is being studied in China

The agreement with China Medical University is one of...

Intervju
Video
CLS

CLS prioritizes neurosurgery over urology

The decision to narrow the focus to brain tumors and...

Intervju
Video
BiBBInstruments

BiBB creates interest

Cancer diagnostics company BiBBInstruments releases new report for...

Intervju
Video
Magle Group

How Magle Group focuses their use of DSM

The company aims to establish itself as a...

Intervju
Video
WntResearch

The big decision for WntResearch

This fall, the results from the phase II study will be...

Intervju
Video
Alligator Investor

BioStock Investor Pitch: Alligator Bioscience

How is Alligator Bioscience preparing to go...

Intervju
Video

BioStock

  • Start
  • News
  • VIDEO
  • Podcast
  • Event
  • About BioStock
  • Privacy Policy
  • Terms and Conditions

Read BioStock's newsletter

Get industry news, company information and invitations to BioStock events directly in your inbox!

Val*
This field is used for validation purposes and should be left unchanged.
© 2025 Biostock